首页> 美国卫生研究院文献>JIMD Reports >Characterization of Phenyalanine Hydroxylase Gene Mutations in Chilean PKU Patients
【2h】

Characterization of Phenyalanine Hydroxylase Gene Mutations in Chilean PKU Patients

机译:智利PKU患者苯丙氨酸羟化酶基因突变的表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Phenylketonuria (PKU, OMIM 261600) is an autosomal recessive disease, caused by mutations in the Phenylalanine Hydroxylase (PAH) gene situated in chromosome 12q22-q24.2. This gene has 13 exons. To date, 991 mutations have been described. The genotype is one of the main factors that determine the phenotype of this disease. Objective: Characterize PKU genotype and phenotype seen in Chilean PKU patients. Methods: We studied the PAH gene by restriction fragment length polymorphism (RFLP) and/or sequencing techniques to identify pathogenic mutations in 71 PKU subjects. We classified the phenotype according to Guldberg predicted value. Results: We identified 26 different mutations in 134 of the 142 alleles studied (94.4%), 88.7% of the subjects had biallelic pathogenic mutations while 11.3% had only one pathogenic mutation identified. Compound heterozygous represented 85.9% of the cases. Exon 7 included the majority of mutations (26.9%) and 50% of mutations were missense. The most frequent mutations were c.1066-11G > A, c.442-?_509+?del and p.Val388Met. The majority of subjects (52.3%) had the classic phenotype. Conclusions: The most frequent mutations in our Chilean PKU population were p.Val388Met, c.442?_509+?del and c.1066-11G > A. It is possible to predict phenotype by detecting the genotype, and use this information to determine disease prognosis and adjust patient’s medical and nutritional management accordingly.
机译:苯丙酮尿症(PKU,OMIM 261600)是一种常染色体隐性遗传疾病,由位于12q22-q24.2染色体上的苯丙氨酸羟化酶(PAH)基因突变引起。该基因具有13个外显子。迄今为止,已经描述了991种突变。基因型是决定该疾病表型的主要因素之一。目的:鉴定智利PKU患者的PKU基因型和表型。方法:我们通过限制性片段长度多态性(RFLP)和/或测序技术研究了PAH基因,以鉴定71名PKU受试者的致病性突变。我们根据Guldberg预测值对表型进行分类。结果:我们在所研究的142个等位基因中的134个中鉴定了26个不同的突变(94.4%),其中88.7%的受试者具有双等位基因致病突变,而11.3%的受试者仅鉴定出一个致病突变。复合杂合子占病例的85.9%。外显子7包括大部分突变(26.9%),并且50%的突变是错义的。最常见的突变是c.1066-11G> A,c.442-Δ_509+Δdel和p.Val388Met。大多数受试者(52.3%)具有经典表型。结论:我们智利PKU人群中最常见的突变是p.Val388Met,c.442?_509 +?del和c.1066-11G> A。可以通过检测基因型来预测表型,并使用此信息来确定疾病预后并相应调整患者的医疗和营养管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号